Chinese biotech Hutchmed today announces that the New Drug Application (NDA) for fanregratinib (HMPL-453) for the treatment of adult patients with advanced, metastatic or unresectable intrahepatic ...
As many people consider lifestyle changes at the start of the year, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is urging the public to make sure any weight-loss medicines they ...
Against the backdrop of a turbulent year marked by both breakthrough and setbacks, the biopharmaceutical industry is entering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback